Sny Stock Symbol Overview and Insights

The Sny stock symbol is listed on the NYSE American stock exchange under the ticker symbol SNY.

Sny is a well-established company with a history dating back to 1926, making it one of the oldest companies in the industry.

The company has a market capitalization of over $20 billion, indicating its significant size and influence in the market.

Sny operates in the diversified industrials sector, which includes a range of industries such as construction, mining, and manufacturing.

Sny stock symbol has a market cap of 136,240,161,000. Its primary exchange is NASDAQ.

The stock's day range is between 53.805 and 54.34, while its year range is between 45 and 58.

Here are some key statistics for Sanofi, the company behind the Sny stock symbol:

As of the current year, Sanofi's revenue estimates are being tracked by 18 analysts, with an average estimate of 48,795 USD.

Sanofi ADR in USD is a great investment opportunity, especially considering the company's revenue growth. Sanofi's revenue is estimated to reach 48,795 USD in 2025, 52,062 USD in 2026, 54,318 USD in 2027, 56,540 USD in 2028, and 59,094 USD in 2029.

The dividend yield for Sanofi ADR in USD is expected to increase over the next few years, from 3.89% in 2025 to 4.82% in 2029. The dividend payout is also expected to rise, from 2.11 USD in 2025 to 2.62 USD in 2029.

Sanofi's earnings per share (EPS) are projected to grow significantly, from 4.32 USD in 2025 to 6.23 USD in 2029. This growth is expected to be driven by the company's increasing revenue and profitability.

Here's a breakdown of Sanofi's estimated financial metrics for 2025-2029:

Sanofi's net profit is expected to increase from 10,325 USD in 2025 to 14,775 USD in 2029. The company's free cash flow is also projected to rise, from 10,698 USD in 2025 to 14,077 USD in 2029.

Sanofi's research and development expenses are expected to increase from 7,910 USD in 2025 to 9,037 USD in 2029. The company's capital expenditure is also projected to rise, from 2,464 USD in 2025 to 2,598 USD in 2029.

Overall, Sanofi ADR in USD appears to be a promising investment opportunity, with strong revenue growth, increasing dividend yield, and rising earnings per share.

Stock performance is a crucial aspect of any investment. The previous close of a stock can give you an idea of its current value, which in this case was 54.15.

The day's trading range is also a significant indicator, as it shows the high and low prices the stock has reached. In this case, the day range was 53.805 to 54.34.

This range can help you understand the stock's volatility and potential for growth. The year range, on the other hand, shows the stock's performance over a longer period, which in this case was 45 to 58.

A stock's market capitalization is another important factor to consider, as it gives you an idea of its size and potential for future growth. In this case, the market cap was 136,240,161,000.

Here's a summary of the key statistics:

Analysts are predicting a strong future for SNY stock, with one analyst giving it a "Strong Buy" rating and forecasting a 12-month stock price of $60.0.

The average earnings estimate for the current quarter is $0.841 USD, based on 5 analyst estimates. This is a significant increase from the previous quarter's average estimate of $0.701 USD.

SNY stock is expected to see a significant increase in revenue, with an average estimate of $48,795 USD for the current year, up from $44,437 USD last year. This growth is expected to continue into the next year, with an average estimate of $52,062 USD.

Here are the average earnings and revenue estimates for the next few quarters:

The number of analysts estimating earnings has been increasing, from 7 in the previous quarter to 20 in the current quarter. This increased consensus suggests that analysts are becoming more confident in their predictions for SNY stock's future performance.

As an investor, it's essential to understand the company's dividend policy and history. The dividend yield is currently at 3.79%, which is a relatively stable figure.

The company has a dividend payout ratio of 0.68, indicating that it's distributing about 68% of its earnings to shareholders. This is a reasonable amount, considering the industry average.

Over the past three years, the company has managed to grow its dividend at a rate of 4.2%. This is a positive sign, as it shows the company's commitment to rewarding its shareholders.

Here's a summary of the key dividend metrics:

These metrics give you a clear picture of the company's dividend policy and its potential for growth.